Viewing Study NCT04759469



Ignite Creation Date: 2024-05-06 @ 3:47 PM
Last Modification Date: 2024-10-26 @ 1:57 PM
Study NCT ID: NCT04759469
Status: COMPLETED
Last Update Posted: 2021-03-22
First Post: 2021-02-15

Brief Title: Effect of Exercise on Cardiometabolic Risk Factors in Type II Diabetic Patients
Sponsor: Cairo University
Organization: Cairo University

Study Overview

Official Title: Effect of Time-efficient Exercise Training on Cardiometabolic Risk Factors in Type II Diabetic Patients A Randomized Mixed-methods Feasibility Study
Status: COMPLETED
Status Verified Date: 2021-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Background Physical activity is known to modify some of the diabetes risk factors however solid evidence is still needed to precisely know the optimum form of training best fits the individual needs of type II diabetic T2D patients
Detailed Description: Objectives the purpose of this study was to compare between high intensity interval training HIIT and moderate-intensity interval training MIIT effect on functional capacity as a cardiorespiratory parameter and on glucose control and glycated hemoglobin HbA1C as metabolic parameters in T2D patients and to test exercise acceptability within these patients Methods 60 participants had participated in this study Their ages ranged from 45 to 65 years They were randomized into two equal groups 30group group A did HIIT and group B did MIIT Both groups received 12 weeks of training Measurements for six minute walking distance 6MWD fasting blood glucose FBG and HbA1C levels were done before and after the study Physical activity enjoyment scale PACES were filled by the patients by the end of the study testing exercise enjoyment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None